GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumos Diagnostics Holdings Ltd (ASX:LDX) » Definitions » Treasury Stock

Lumos Diagnostics Holdings (ASX:LDX) Treasury Stock : A$0.00 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Lumos Diagnostics Holdings's treasury stock for the quarter that ended in Jun. 2024 was A$0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.


Lumos Diagnostics Holdings Treasury Stock Historical Data

The historical data trend for Lumos Diagnostics Holdings's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumos Diagnostics Holdings Treasury Stock Chart

Lumos Diagnostics Holdings Annual Data
Trend Jun22 Jun23 Jun24
Treasury Stock
- - -

Lumos Diagnostics Holdings Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Treasury Stock Get a 7-Day Free Trial - - - - -

Lumos Diagnostics Holdings Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.


Lumos Diagnostics Holdings Business Description

Traded in Other Exchanges
Address
2724 Loker Ave West, Carlsbad, CA, USA, 92010
Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. It also directly develops, manufactures and commercializes proprietary, Lumos-branded POC tests that target infectious and inflammatory diseases. It generates maximum revenue from the commercial services and solutions relating to POC diagnostic tests.

Lumos Diagnostics Holdings Headlines

No Headlines